Global In Vitro Diagnostic Chip Market Growth 2025-2031
Description
The global In Vitro Diagnostic Chip market size is predicted to grow from US$ 3067 million in 2025 to US$ 5034 million in 2031; it is expected to grow at a CAGR of 8.6% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
In Vitro Diagnostic Chip is a miniaturized lab platform used for the rapid detection of disease-related biomarkers in human samples outside the body, commonly applied in precision medicine and point-of-care testing (POCT).
United States market for In Vitro Diagnostic Chip is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for In Vitro Diagnostic Chip is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for In Vitro Diagnostic Chip is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key In Vitro Diagnostic Chip players cover Roche Diagnostics, Siemens Healthineers, Abbott Laboratories, Danaher Corporation, bioMérieux, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “In Vitro Diagnostic Chip Industry Forecast” looks at past sales and reviews total world In Vitro Diagnostic Chip sales in 2024, providing a comprehensive analysis by region and market sector of projected In Vitro Diagnostic Chip sales for 2025 through 2031. With In Vitro Diagnostic Chip sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world In Vitro Diagnostic Chip industry.
This Insight Report provides a comprehensive analysis of the global In Vitro Diagnostic Chip landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on In Vitro Diagnostic Chip portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global In Vitro Diagnostic Chip market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for In Vitro Diagnostic Chip and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global In Vitro Diagnostic Chip.
This report presents a comprehensive overview, market shares, and growth opportunities of In Vitro Diagnostic Chip market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Nucleic Acid Detection Chips
Protein Detection Chips
Cell Analysis Chips
Multiplex Analysis Chips
Others
Segmentation by Application:
Infectious Disease Detection
Cancer Screening and Monitoring
Chronic Disease Management
Genetic Disorder Testing
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Roche Diagnostics
Siemens Healthineers
Abbott Laboratories
Danaher Corporation
bioMérieux
QIAGEN
Thermo Fisher Scientific
Agilent Technologies
Illumina
PerkinElmer
Merck KGaA
Becton, Dickinson and Company
Sysmex Corporation
Biotronik
Randox Laboratories
Key Questions Addressed in this Report
What is the 10-year outlook for the global In Vitro Diagnostic Chip market?
What factors are driving In Vitro Diagnostic Chip market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do In Vitro Diagnostic Chip market opportunities vary by end market size?
How does In Vitro Diagnostic Chip break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
In Vitro Diagnostic Chip is a miniaturized lab platform used for the rapid detection of disease-related biomarkers in human samples outside the body, commonly applied in precision medicine and point-of-care testing (POCT).
United States market for In Vitro Diagnostic Chip is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for In Vitro Diagnostic Chip is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for In Vitro Diagnostic Chip is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key In Vitro Diagnostic Chip players cover Roche Diagnostics, Siemens Healthineers, Abbott Laboratories, Danaher Corporation, bioMérieux, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “In Vitro Diagnostic Chip Industry Forecast” looks at past sales and reviews total world In Vitro Diagnostic Chip sales in 2024, providing a comprehensive analysis by region and market sector of projected In Vitro Diagnostic Chip sales for 2025 through 2031. With In Vitro Diagnostic Chip sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world In Vitro Diagnostic Chip industry.
This Insight Report provides a comprehensive analysis of the global In Vitro Diagnostic Chip landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on In Vitro Diagnostic Chip portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global In Vitro Diagnostic Chip market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for In Vitro Diagnostic Chip and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global In Vitro Diagnostic Chip.
This report presents a comprehensive overview, market shares, and growth opportunities of In Vitro Diagnostic Chip market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Nucleic Acid Detection Chips
Protein Detection Chips
Cell Analysis Chips
Multiplex Analysis Chips
Others
Segmentation by Application:
Infectious Disease Detection
Cancer Screening and Monitoring
Chronic Disease Management
Genetic Disorder Testing
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Roche Diagnostics
Siemens Healthineers
Abbott Laboratories
Danaher Corporation
bioMérieux
QIAGEN
Thermo Fisher Scientific
Agilent Technologies
Illumina
PerkinElmer
Merck KGaA
Becton, Dickinson and Company
Sysmex Corporation
Biotronik
Randox Laboratories
Key Questions Addressed in this Report
What is the 10-year outlook for the global In Vitro Diagnostic Chip market?
What factors are driving In Vitro Diagnostic Chip market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do In Vitro Diagnostic Chip market opportunities vary by end market size?
How does In Vitro Diagnostic Chip break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
109 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for In Vitro Diagnostic Chip by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for In Vitro Diagnostic Chip by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
